Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy.
J Pediatr Pharmacol Ther. 2019 May-Jun;24(3):194-203. doi: 10.5863/1551-6776-24.3.194.
J Pediatr Pharmacol Ther. 2019.
PMID: 31093018
Free PMC article.
Review.